^
BIOMARKER:

NTRK3 fusion

i
Other names: NTRK3, TRKC, Neurotrophic tyrosine kinase, receptor, type 3
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
NTRK3 fusion
Solid Tumor
larotrectinib
Sensitive
:
A1
ESMO 2022 - 3 weeks - (New C3)
NTRK3 fusion
Sarcoma
larotrectinib
Sensitive
:
A1
NTRK3 fusion
Solid Tumor
entrectinib
Sensitive
:
A1
NTRK3 fusion
Small Intestinal Carcinoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Thyroid Gland Follicular Carcinoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Thyroid Gland Follicular Carcinoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Breast Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Gastrointestinal Stromal Tumor
entrectinib
Sensitive
:
A2
NTRK3 fusion
Sarcoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Peritoneal Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Peritoneal Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Fallopian Tube Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Fallopian Tube Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Non Small Cell Lung Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Pancreatic Adenocarcinoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Endometrial Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Gastrointestinal Stromal Tumor
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Small Intestinal Carcinoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Pancreatic Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Pancreatic Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Thyroid Gland Papillary Carcinoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Gastroesophageal Junction Adenocarcinoma
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Esophageal Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Gastroesophageal Junction Adenocarcinoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Esophageal Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Cervical Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Cervical Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Non Small Cell Lung Cancer
entrectinib
Sensitive
:
A2
NTRK3 fusion
Biliary Tract Cancer
larotrectinib
Sensitive
:
A2